ANDROGEN SUPPRESSION PLUS RADIATION VERSUS RADIATION ALONE FOR PATIENTS WITH D1 (PN-85-31)() ADENOCARCINOMA OF THE PROSTATE (RESULTS BASED ON A NATIONAL PROSPECTIVE RANDOMIZED TRIAL, RTOG)
Ca. Lawton et al., ANDROGEN SUPPRESSION PLUS RADIATION VERSUS RADIATION ALONE FOR PATIENTS WITH D1 (PN-85-31)() ADENOCARCINOMA OF THE PROSTATE (RESULTS BASED ON A NATIONAL PROSPECTIVE RANDOMIZED TRIAL, RTOG), International journal of radiation oncology, biology, physics, 38(5), 1997, pp. 931-939
Citations number
20
Categorie Soggetti
Oncology,"Radiology,Nuclear Medicine & Medical Imaging
Purpose: To evaluate the effect of immediate androgen suppression in c
onjunction with standard external beam irradiation vs, radiation alone
on a group of pathologically staged lymph node-positive patients with
adenocarcinoma of the prostate, Methods and Materials: A national pro
spective randomized trial (RTOG 85-31) of standard external beam irrad
iation plus immediate androgen suppression vs, external beam irradiati
on alone was initiated in 1985 for patients with locally advanced aden
ocarcinoma of the prostate, One hundred seventy-three of the patients
in this trial had biopsy-proven pathologically involved lymph nodes, N
inety-eight of these patients received radiation plus the immediate an
drogen suppression (LHRH agonist), while 75 received radiation alone w
ith hormonal manipulation instituted at the time of relapse, Results:
With a median followup of 4.9 years, estimated progression-free surviv
al with PSA < 1.5 ng/ml at 5 years was 55% for the patients who receiv
ed radiation plus immediate LHRH agonist vs, 11% of the patients who r
eceived radiation alone with hormonal manipulation at relapse (p = 0.0
001), Because all of these patients had locally advanced disease (i.e.
, pathologically positive lymph nodes), stage does not explain this di
fference in outcome, and Gleason grade was not statistically different
between the two groups, Estimated absolute survival at 5 years for th
e radiation and LHRH group was 73 vs, 65% for the radiation alone grou
p who received androgen suppression at relapse, Estimated disease-spec
ific survival at 5 years was 82% for the radiation and immediate LHRH
agonist group and 77% for the radiation-alone group, Conclusion: Patie
nts with adenocarcinoma of the prostate and pathologically involved pe
lvic lymph nodes (pN+ or clinical stage D1) should be seriously consid
ered for external beam irradiation plus immediate hormonal manipulatio
n over radiation alone with hormonal manipulation at the time of relap
se. (C) 1997 Elsevier Science Inc.